Brower Piven Encourages Investors Who Have Losses in Excess of $500,000 From Investment in Allscripts Healthcare Solutions, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the July 2, 2012 Lead Plaintiff Deadline

Marketwired

STEVENSON, MD--(Marketwire -05/04/12)- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois on behalf of purchasers of the common stock of Allscripts Healthcare Solutions, Inc. ("Allscripts" or the "Company") (MDRX - News) during the period between November 9, 2010 and April 26, 2012, inclusive (the "Class Period").

If you have suffered a net loss for all transactions in Allscripts Healthcare Solutions, Inc. common stock during the Class Period, you may obtain additional information about this lawsuit and your ability to become a lead plaintiff by contacting Brower Piven at www.browerpiven.com, by email at hoffman@browerpiven.com, by calling 410/415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and class action cases of over 60 years.

No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff no later than July 2, 2012 and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the Company during the Class Period. You are not required to have sold your shares to seek damages or to serve as a Lead Plaintiff.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the Company's failure to disclose during the Class Period, that the process of developing a unified product offering after the merger of Allscripts-Misys Healthcare Solutions, Inc. and Eclypsis Corporation in August 2010 had suffered debilitating setbacks, including major undisclosed schisms among the most senior levels of the Company, which ultimately resulted in the loss of key personnel and harmful upheaval in Company leadership, that a material portion of Allscripts' revenue and net income was predicated on the successful integration of these systems, and substantial business relationships had been destroyed by the Company's inability to make material progress in this area. According to the complaint, after, on April 26, 2012, the Company reported earnings sharply below guidance and expectations, as well as the termination of the Chairman of its Board of Directors, the resignation of three Company directors, and the resignation the Company's Chief Financial Officer, the value of Allscripts shares declined significantly.

If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

Contact:
CONTACT:
Charles J. Piven
Brower Piven, A Professional Corporation
Stevenson, Maryland
410/415-6616
Email Contact

View Comments (0)